181 related articles for article (PubMed ID: 34207414)
21. Evaluation of Tumor infiltrating lymphocytes in breast carcinoma and their correlation with molecular subtypes, tumor grade and stage.
Pujani M; Jain H; Chauhan V; Agarwal C; Singh K; Singh M
Breast Dis; 2020; 39(2):61-69. PubMed ID: 32310155
[TBL] [Abstract][Full Text] [Related]
22. LAG-3 expression in tumor microenvironment of triple-negative breast cancer.
Tahtacı G; Günel N; Sadioğlu A; Akyürek N; Boz O; Üner A
Turk J Med Sci; 2023 Feb; 53(1):142-148. PubMed ID: 36945923
[TBL] [Abstract][Full Text] [Related]
23. Prognostic role of stromal tumor-infiltrating lymphocytes in locally advanced upper tract urothelial carcinoma: A retrospective multicenter study (TSU-02 study).
Cheng S; Zhong W; Xia K; Hong P; Lin R; Wang B; Li X; Chen J; Liu Z; Zhang H; Liu C; Ye L; Ma L; Lin T; Li X; Huang J; Zhou L
Oncoimmunology; 2021 Jan; 10(1):1861737. PubMed ID: 33489471
[TBL] [Abstract][Full Text] [Related]
24. Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials.
Dieci MV; Mathieu MC; Guarneri V; Conte P; Delaloge S; Andre F; Goubar A
Ann Oncol; 2015 Aug; 26(8):1698-704. PubMed ID: 25995301
[TBL] [Abstract][Full Text] [Related]
25. Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes for prediction of prognosis in resected colon cancer.
Lim Y; Choi S; Oh HJ; Kim C; Song S; Kim S; Song H; Park S; Kim JW; Kim JW; Kim JH; Kang M; Kang SB; Kim DW; Oh HK; Lee HS; Lee KW
NPJ Precis Oncol; 2023 Nov; 7(1):124. PubMed ID: 37985785
[TBL] [Abstract][Full Text] [Related]
26. Body Mass Index and Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.
Floris G; Richard F; Hamy AS; Jongen L; Wildiers H; Ardui J; Punie K; Smeets A; Berteloot P; Vergote I; De Croze D; Meseure D; Salomon A; Laé M; Reyal F; Biganzoli E; Neven P; Desmedt C
J Natl Cancer Inst; 2021 Feb; 113(2):146-153. PubMed ID: 33152071
[TBL] [Abstract][Full Text] [Related]
27. Interobserver Agreement Between Pathologists Assessing Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer Using Methodology Proposed by the International TILs Working Group.
Swisher SK; Wu Y; Castaneda CA; Lyons GR; Yang F; Tapia C; Wang X; Casavilca SA; Bassett R; Castillo M; Sahin A; Mittendorf EA
Ann Surg Oncol; 2016 Jul; 23(7):2242-8. PubMed ID: 26965699
[TBL] [Abstract][Full Text] [Related]
28. [Correlation analysis of PD-L1 expression and prognosis in triple-negative breast cancers].
Pan BJ; Xu C; Ping GQ; Song GX; Zhang WM; Wang C; Zhang ZH
Zhonghua Bing Li Xue Za Zhi; 2017 Dec; 46(12):822-826. PubMed ID: 29224274
[No Abstract] [Full Text] [Related]
29. Tumour Stroma Ratio Assessment Using Digital Image Analysis Predicts Survival in Triple Negative and Luminal Breast Cancer.
Millar EK; Browne LH; Beretov J; Lee K; Lynch J; Swarbrick A; Graham PH
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33322174
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the Predictive and Prognostic Values of Stromal Tumor-Infiltrating Lymphocytes in HER2-Positive Breast Cancers treated with neoadjuvant chemotherapy.
Yang X; Rao J; Yang W; Shui R
Target Oncol; 2018 Dec; 13(6):757-767. PubMed ID: 30406444
[TBL] [Abstract][Full Text] [Related]
31. Clinical Meaning of Stromal Tumor Infiltrating Lymphocytes (sTIL) in Early Luminal B Breast Cancer.
García-Torralba E; Pérez Ramos M; Ivars Rubio A; Navarro-Manzano E; Blaya Boluda N; de la Morena Barrio P; García-Garre E; Martínez Díaz F; Chaves-Benito A; García-Martínez E; Ayala de la Peña F
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345183
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological predictors of long-term benefit in breast cancer treated with neoadjuvant chemotherapy.
Galvez M; Castaneda CA; Sanchez J; Castillo M; Rebaza LP; Calderon G; Cruz M; Cotrina JM; Abugattas J; Dunstan J; Guerra H; Mejia O; Gomez HL
World J Clin Oncol; 2018 Apr; 9(2):33-41. PubMed ID: 29651385
[TBL] [Abstract][Full Text] [Related]
33. Hot Spot and Whole-Tumor Enumeration of CD8
McIntire PJ; Irshaid L; Liu Y; Chen Z; Menken F; Nowak E; Shin SJ; Ginter PS
Clin Breast Cancer; 2018 Dec; 18(6):451-458.e1. PubMed ID: 29866579
[TBL] [Abstract][Full Text] [Related]
34. Reproducibility and predictive value of scoring stromal tumour infiltrating lymphocytes in triple-negative breast cancer: a multi-institutional study.
O'Loughlin M; Andreu X; Bianchi S; Chemielik E; Cordoba A; Cserni G; Figueiredo P; Floris G; Foschini MP; Heikkilä P; Kulka J; Liepniece-Karele I; Regitnig P; Reiner A; Ryska A; Sapino A; Shalaby A; Stovgaard ES; Quinn C; Walsh EM; Zolota V; Glynn SA; Callagy G
Breast Cancer Res Treat; 2018 Aug; 171(1):1-9. PubMed ID: 29774470
[TBL] [Abstract][Full Text] [Related]
35. A Novel Digital Score for Abundance of Tumour Infiltrating Lymphocytes Predicts Disease Free Survival in Oral Squamous Cell Carcinoma.
Shaban M; Khurram SA; Fraz MM; Alsubaie N; Masood I; Mushtaq S; Hassan M; Loya A; Rajpoot NM
Sci Rep; 2019 Sep; 9(1):13341. PubMed ID: 31527658
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Impact of High Baseline Stromal Tumor-Infiltrating Lymphocytes in the Absence of Pathologic Complete Response in Early-Stage Triple-Negative Breast Cancer.
Abuhadra N; Sun R; Litton JK; Rauch GM; Yam C; Chang JT; Seth S; Bassett R; Lim B; Thompson AM; Mittendorf E; Adrada BE; Damodaran S; White J; Ravenberg E; Candelaria R; Arun B; Ueno NT; Santiago L; Saleem S; Abouharb S; Murthy RK; Ibrahim N; Sahin AA; Valero V; Symmans WF; Tripathy D; Moulder S; Huo L
Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267631
[TBL] [Abstract][Full Text] [Related]
37. Tumor-infiltrating lymphocyte enrichment predicted by CT radiomics analysis is associated with clinical outcomes of non-small cell lung cancer patients receiving immune checkpoint inhibitors.
Park C; Jeong DY; Choi Y; Oh YJ; Kim J; Ryu J; Paeng K; Lee SH; Ock CY; Lee HY
Front Immunol; 2022; 13():1038089. PubMed ID: 36660547
[TBL] [Abstract][Full Text] [Related]
38. The Evolution and Prognostic Role of Tumour-Infiltrating Lymphocytes and Peripheral Blood-Based Biomarkers in Inflammatory Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
Van Berckelaer C; Vermeiren I; Vercauteren L; Rypens C; Oner G; Trinh XB; Tjalma WAA; Broeckx G; Charafe-Jauffret E; Van Laere S; Bertucci F; Colpaert C; van Dam PA
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572883
[TBL] [Abstract][Full Text] [Related]
39. Intra-Tumour Heterogeneity Is One of the Main Sources of Inter-Observer Variation in Scoring Stromal Tumour Infiltrating Lymphocytes in Triple Negative Breast Cancer.
Kilmartin D; O'Loughlin M; Andreu X; Bagó-Horváth Z; Bianchi S; Chmielik E; Cserni G; Figueiredo P; Floris G; Foschini MP; Kovács A; Heikkilä P; Kulka J; Laenkholm AV; Liepniece-Karele I; Marchiò C; Provenzano E; Regitnig P; Reiner A; Ryška A; Sapino A; Specht Stovgaard E; Quinn C; Zolota V; Webber M; Roshan D; Glynn SA; Callagy G
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503219
[TBL] [Abstract][Full Text] [Related]
40. Clinical validity of tumor-infiltrating lymphocytes analysis in patients with triple-negative breast cancer.
Pruneri G; Vingiani A; Bagnardi V; Rotmensz N; De Rose A; Palazzo A; Colleoni AM; Goldhirsch A; Viale G
Ann Oncol; 2016 Feb; 27(2):249-56. PubMed ID: 26598540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
